Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26121 | 21067942 | Trends Endocrinol Metab | Fructose induced lipogenesis: from sugar to fat to insulin resistance. | 2010 | Details |
| A26123 | 21057163 | Ann Hepatol | G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients. | 2011 | Details |
| A26124 | 21057159 | Ann Hepatol | Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. | 2011 | Details |
| A26126 | 21055684 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26127 | 21054523 | J Gastroenterol Hepatol | Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. | 2011 | Details |
| A26131 | 21045794 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in nonalcoholic fatty liver disease. | 2010 | Details |
| A26132 | 21044019 | Curr Vasc Pharmacol | Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years. | 2011 | Details |
| A26136 | 21042270 | Minerva Pediatr | [Pediatric non-alcoholic fatty liver disease: recent advances and challenges]. | 2010 | Details |
| A26138 | 21040936 | Metabolism | The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study). | 2010 | Details |
| A26140 | 21040407 | Liver Int | Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. | 2010 | Details |
| A26153 | 21033079 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease as an atherosclerosis risk factor]. | 2010 | Details |
| A26154 | 23051943 | Indian J Med Sci | Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance. | 2010 | Details |
| A26155 | 21030787 | Exp Anim | Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. | 2010 | Details |
| A26156 | 21029639 | Zhonghua Yi Xue Za Zhi | [Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome]. | 2010 | Details |
| A26168 | 20966900 | Obesity (Silver Spring) | Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study. | 2010 | Details |
| A26169 | 20965162 | Eur J Pharmacol | The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. | 2010 | Details |
| A26171 | 20961734 | Nutrition | Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. | 2010 | Details |
| A26172 | 20961180 | Scand J Clin Lab Invest | Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age. | 2010 | Details |
| A26173 | 20960378 | Semin Liver Dis | Novel insights into the pathophysiology of nonalcoholic fatty liver disease. | 2010 | Details |
| A26175 | 20955971 | Best Pract Res Clin Gastroenterol | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26176 | 20955440 | Aliment Pharmacol Ther | Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. | 2010 | Details |
| A26177 | 20953581 | Diabetologia | Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase. | 2010 | Details |
| A26178 | 20950125 | Int J Pediatr Obes | Vascular function in obese children with non-alcoholic fatty liver disease. | 2010 | Details |
| A26179 | 20947198 | J Hepatol | Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. | 2010 | Details |
| A26180 | 20946638 | Lipids Health Dis | Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. | 2010 | Details |
| A26181 | 20945272 | Horm Metab Res | A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis. | 2010 | Details |
| A26184 | 20942739 | Scand J Clin Lab Invest | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Details |
| A26186 | 20939106 | World J Gastroenterol | Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. | 2010 | Details |
| A26187 | 20939105 | World J Gastroenterol | Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. | 2010 | Details |
| A26190 | 20938947 | Hepatology | Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. | 2010 | Details |
| A26197 | 20926473 | Ann Clin Biochem | Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. | 2010 | Details |
| A26199 | 20923528 | J Diabetes | Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. | 2009 | Details |
| A26200 | 20922498 | Obes Surg | NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. | 2011 | Details |
| A26202 | 20890895 | Hepatology | Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. | 2010 | Details |
| A26203 | 20890890 | Hepatology | Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. | 2010 | Details |
| A26204 | 20888782 | Trends Endocrinol Metab | JNK regulation of hepatic manifestations of the metabolic syndrome. | 2010 | Details |
| A26205 | 20888662 | J Hepatol | Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. | 2010 | Details |
| A26208 | 20887718 | Clin Chim Acta | Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome. | 2010 | Details |
| A26209 | 20887595 | Hepatol Res | Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. | 2010 | Details |
| A26212 | 20880682 | Nutr Metab Cardiovasc Dis | Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. | 2010 | Details |
| A26213 | 20880342 | Diabetes Obes Metab | Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events. | 2010 | Details |
| A26217 | 28839568 | Frontline Gastroenterol | Practical management of the increasing burden of non-alcoholic fatty liver disease. | 2010 | Details |
| A26222 | 20872965 | World J Gastroenterol | Roles of liver innate immune cells in nonalcoholic fatty liver disease. | 2010 | Details |
| A26223 | 20871475 | Pancreas | Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. | 2010 | Details |
| A26224 | 20869214 | Exp Toxicol Pathol | Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. | 2010 | Details |
| A26225 | 20869086 | Metabolism | Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A26227 | 20865675 | Cardiol J | Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26228 | 20865648 | Horm Metab Res | Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. | 2010 | Details |
| A26231 | 20858684 | Diabetes | Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. | 2010 | Details |
| A26232 | 20858492 | Gastroenterology | Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. | 2010 | Details |
| A26233 | 20851820 | QJM | Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. | 2010 | Details |
| A26239 | 20847373 | Indian J Med Res | Association of hypoadiponectinemia with non-alcoholic fatty liver disease in urban south Indians--(CURES - 81). | 2010 | Details |
| A26243 | 20845385 | Biotechnol J | Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. | 2010 | Details |
| A26245 | 20842602 | Swiss Med Wkly | Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. | 2010 | Details |
| A26246 | 20842510 | J Gastroenterol | A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26247 | 20842181 | Nat Rev Endocrinol | Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. | 2010 | Details |
| A26249 | 20842026 | Curr Opin Clin Nutr Metab Care | Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. | 2010 | Details |
| A26250 | 20840346 | J Eur Acad Dermatol Venereol | Psoriasis and non-alcoholic fatty liver disease. | 2010 | Details |
| A26251 | 20838401 | Int J Obes (Lond) | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2010 | Details |
| A26252 | 20836990 | Biochem Biophys Res Commun | Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. | 2010 | Details |
| A26254 | 20828853 | J Hepatol | Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. | 2010 | Details |
| A26257 | 20825652 | BMC Gastroenterol | Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. | 2010 | Details |
| A26259 | 20818807 | World J Gastroenterol | Obstructive sleep apnea syndrome and fatty liver: association or causal link? | 2010 | Details |
| A26260 | 20818484 | Int J Mol Med | Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
| A26263 | 20817213 | Metabolism | Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. | 2010 | Details |
| A26264 | 20815776 | Free Radic Res | Palmitate protects hepatocytes from oxidative stress and triacylglyceride accumulation by stimulation of nitric oxide synthesis in the presence of high glucose and insulin concentration. | 2010 | Details |
| A26266 | 20809771 | Scand J Gastroenterol | Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A26270 | 20805868 | PLoS One | Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. | 2010 | Details |
| A26272 | 20804522 | Obes Rev | Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? | 2010 | Details |
| A26273 | 20803499 | Hepatology | A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. | 2010 | Details |
| A26275 | 20801631 | J Nutr Biochem | An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. | 2010 | Details |
| A26276 | 20801629 | J Nutr Biochem | Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. | 2010 | Details |
| A26278 | 20798875 | J Obes | Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26283 | 20731535 | Ups J Med Sci | Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. | 2010 | Details |
| A26286 | 20731108 | Ter Arkh | [Association of obstructive sleep apnea syndrome with the signs of nonalcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome]. | 2010 | Details |
| A26288 | 20721461 | Arq Gastroenterol | Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. | 2010 | Details |
| A26289 | 20720269 | Ann Hepatol | Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. | 2010 | Details |
| A26294 | 20701585 | Curr Diabetes Rev | Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. | 2010 | Details |
| A26296 | 20694293 | Nutr Hosp | Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. | 2011 | Details |
| A26297 | 20687985 | Acta Med Port | [Association of gamma glutamyltransferase, metabolic syndrome and cardiovascular risk]. | 2010 | Details |
| A26310 | 20664312 | Korean J Gastroenterol | [Nonalcoholic fatty liver disease]. | 2010 | Details |
| A26312 | 20661251 | Int J Obes (Lond) | Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. | 2010 | Details |
| A26314 | 20660697 | Gut | Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. | 2010 | Details |
| A26316 | 20658156 | J Gastroenterol | Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26321 | 20653983 | Lipids Health Dis | Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. | 2010 | Details |
| A26322 | 20651844 | Biochem Cell Biol | Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. | 2010 | Details |
| A26323 | 20651599 | Eur J Gastroenterol Hepatol | Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis. | 2010 | Details |
| A26325 | 20648476 | Hepatology | Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. | 2010 | Details |
| A26326 | 20648474 | Hepatology | I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. | 2010 | Details |
| A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
| A26337 | 20628364 | Am J Gastroenterol | Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. | 2010 | Details |
| A26338 | 20627036 | Zhonghua Nei Ke Za Zhi | [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2010 | Details |
| A26342 | 20625647 | Arq Bras Endocrinol Metabol | Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2010 | Details |
| A26344 | 20624207 | Liver Int | The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. | 2010 | Details |
| A26353 | 20604719 | Scand J Clin Lab Invest | Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26356 | 20601094 | Drug Discov Today | Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation? | 2010 | Details |
| A26358 | 20600015 | Gastroenterology | Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. | 2010 | Details |
| A26361 | 20590731 | Diabetes Obes Metab | Acupuncture: is it effective for treatment of insulin resistance? | 2010 | Details |
| A26362 | 20587319 | Zhonghua Gan Zang Bing Za Zhi | [The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease]. | 2010 | Details |
| A26364 | 20584230 | Int J Clin Pract | Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. | 2010 | Details |